Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze BIB stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate BIB investment potential.

What is BIB stock price today?

Get real-time BIB stock price, historical data, and price charts on Financhill. Track BIB performance with our advanced analysis tools.

Is BIB a good investment?

Evaluate BIB investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy BIB stock?

To buy BIB stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of BIB?

View detailed market capitalization data and company valuation metrics for BIB on our comprehensive analysis page.

What is the P/E ratio of BIB?

Use our fundamental analysis tools to view BIB P/E ratio and compare valuation metrics with industry peers.

What are BIB earnings?

View BIB earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

ProShares Ultra Nasdaq Biotechnology 10K Form

Buy

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:

$82.02

Seasonality Move:

8.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIB News And Ratings

See the #1 stock for the next 7 days that we like better than BIB

BIB Financial Statistics

Sales & Book Value

Annual Sales:	--
Cash Flow:	$0
Price / Cash Flow:	0
Annual Sales:	$0.00
Price / Book:	0

Profitability

Net Income (TTM):	$0
Gross Margin:	--
Return on Equity:	0%
Return on Assets:	0%

ProShares Ultra Nasdaq Biotechnology Earnings Forecast

Key ProShares Ultra Nasdaq Biotechnology Financial Ratios

ProShares Ultra Nasdaq Biotechnology Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Current Symbol:	BIB
CUSIP:	74347R

Debt

Debt-to-Equity Ratio:	0
Current Ratio:	0
Quick Ratio:	0

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

BIB Technical Analysis vs Fundamental Analysis

Buy

ProShares Ultra Nasdaq Biotechnology (BIB) is a Buy

Is ProShares Ultra Nasdaq Biotechnology a Buy or a Sell?

ProShares Ultra Nasdaq Biotechnology stock is rated a Buy

The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $81.96. The Score for BIB is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.